SARS-CoV-2 Spike Glycoprotein RBD Nanobody
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2/COVID-19) Spike Glycoprotein Receptor-Binding Domain Protein Nanobody is a recombinant monoclonal antibody expressed in HEK293 cells for the detection of SARS-CoV-2/COVID-19 S RBD Protein. This antibody contains VHH fused with Human IgG1 Fc at the C-terminus.
The SARS-CoV-2 Spike Protein (S protein) is a viral protein that allows the entry of SARS-CoV-2 into human cells. The protein forms trimers on the viral capsid and binds to human Angiotensin Converting Enzyme 2 (ACE2) located on the cell surface. The protein has a cleavage site between the S1 and S2 subunits that is targeted by the human enzyme Furin, and it may also cause the development of a syncytium (cell fusion). Antibodies to S protein can prevent viral entry as well as target the virus for further immune action.
The SARS-CoV-2 Spike Protein (S protein) is a viral protein that allows the entry of SARS-CoV-2 into human cells. The protein forms trimers on the viral capsid and binds to human Angiotensin Converting Enzyme 2 (ACE2) located on the cell surface. The protein has a cleavage site between the S1 and S2 subunits that is targeted by the human enzyme Furin, and it may also cause the development of a syncytium (cell fusion). Antibodies to S protein can prevent viral entry as well as target the virus for further immune action.
| Supplier | Abbexa Ltd. |
|---|---|
| Product # | abx243130-100UL |
| Pricing | 100 µl USD $812.0 |
| Clonality | Monoclonal |
| Conjugation | Unconjugated |
| Tested Applications | ELISA |
| UniProt Primary AC | P0DTC2 |
| Dry Ice | No |
| Availability | Shipped within 5-10 working days. |
| Note | This product is for research use only. |